160 related articles for article (PubMed ID: 2397938)
1. Susceptibility pattern of bacterial isolates to lomefloxacin.
Lalitha MK; Nisha AK; Bhattacharya SS; Ramamoorthy U; Lal HM
Indian J Med Res; 1990 May; 91():182-4. PubMed ID: 2397938
[TBL] [Abstract][Full Text] [Related]
2. Comparative antimicrobial activity of lomefloxacin, norfloxacin, ofloxacin, ciprofloxacin and enoxacin against > 500 bacterial isolates.
Ismaeel NA; Tayeb OS
Microbios; 1993; 74(300):147-54. PubMed ID: 8396196
[TBL] [Abstract][Full Text] [Related]
3. Comparative in vitro studies with 4-quinolone antimicrobials.
Felmingham D; O'Hare MD; Robbins MJ; Wall RA; Williams AH; Cremer AW; Ridgway GL; Grüneberg RN
Drugs Exp Clin Res; 1985; 11(5):317-29. PubMed ID: 2941259
[TBL] [Abstract][Full Text] [Related]
4. Overview of the fluoroquinolone antibiotics.
Just PM
Pharmacotherapy; 1993; 13(2 Pt 2):4S-17S. PubMed ID: 8386356
[TBL] [Abstract][Full Text] [Related]
5. [In vitro evaluation of lomefloxacin].
Dette GA; Knothe H
Arzneimittelforschung; 1989 Aug; 39(8):832-5. PubMed ID: 2818672
[TBL] [Abstract][Full Text] [Related]
6. Photocleavage of DNA by the fluoroquinolone antibacterials.
Martínez L; Chignell CF
J Photochem Photobiol B; 1998 Aug; 45(1):51-9. PubMed ID: 9819899
[TBL] [Abstract][Full Text] [Related]
7. In-vitro assessment of lomefloxacin (SC-47111)--a new quinolone derivative.
Finch R; Martin J; Pilkington R
J Antimicrob Chemother; 1988 Dec; 22(6):881-4. PubMed ID: 3243735
[TBL] [Abstract][Full Text] [Related]
8. Comparative antimicrobial activity of enoxacin, ciprofloxacin, amifloxacin, norfloxacin and ofloxacin against 177 bacterial isolates.
Bassey CM; Baltch AL; Smith RP
J Antimicrob Chemother; 1986 May; 17(5):623-8. PubMed ID: 2941401
[TBL] [Abstract][Full Text] [Related]
9. Proposed criteria for interpretation of susceptibilities of strains of Neisseria gonorrhoeae to ciprofloxacin, ofloxacin, enoxacin, lomefloxacin, and norfloxacin.
Knapp JS; Hale JA; Neal SW; Wintersheid K; Rice RJ; Whittington WL
Antimicrob Agents Chemother; 1995 Nov; 39(11):2442-5. PubMed ID: 8585723
[TBL] [Abstract][Full Text] [Related]
10. A multicenter study on the comparative in vitro activity of fleroxacin and three other quinolones: an interim report from 27 centers.
Beskid G; Prosser BL
Am J Med; 1993 Mar; 94(3A):2S-8S. PubMed ID: 8383919
[TBL] [Abstract][Full Text] [Related]
11. Development of resistance to nalidixic acid and the fluoroquinolones after the introduction of norfloxacin and ofloxacin.
Kresken M; Wiedemann B
Antimicrob Agents Chemother; 1988 Aug; 32(8):1285-8. PubMed ID: 3142353
[TBL] [Abstract][Full Text] [Related]
12. Lomefloxacin, a new fluoroquinolone. Studies on in vitro antimicrobial spectrum, potency, and development of resistance.
Aldridge KE; Henderberg A; Gebbia K; Schiro DD; Janney A; Sanders CV
Diagn Microbiol Infect Dis; 1989; 12(3):221-33. PubMed ID: 2791485
[TBL] [Abstract][Full Text] [Related]
13. In vitro activity of lomefloxacin, a new difluorinated quinolone, against urinary bacterial isolates: comparison with enoxacin and ofloxacin.
Azadian BS; Talboys CA; Roberts AP
J Chemother; 1989 Jul; 1(4 Suppl):176-7. PubMed ID: 16312357
[No Abstract] [Full Text] [Related]
14. Correlation of in vitro activities of the fluoroquinolones to their in vivo efficacies.
Fernandes PB; Swanson RN
Drugs Exp Clin Res; 1988; 14(6):375-8. PubMed ID: 3145851
[TBL] [Abstract][Full Text] [Related]
15. In vitro susceptibility of selected veterinary bacterial pathogens to ciprofloxacin, enrofloxacin and norfloxacin.
Prescott JF; Yielding KM
Can J Vet Res; 1990 Jan; 54(1):195-7. PubMed ID: 2306672
[TBL] [Abstract][Full Text] [Related]
16. Multicenter in vitro evaluation of lomefloxacin (NY-198, SC-47111), including tests against nearly 7,000 bacterial isolates and preliminary recommendations for susceptibility testing.
Jones RN; Aldridge KE; Barry AL; Fuchs PC; Gerlach EH; Pfaller MA; Washington JA
Diagn Microbiol Infect Dis; 1988 Aug; 10(4):221-40. PubMed ID: 3072151
[TBL] [Abstract][Full Text] [Related]
17. A ten-laboratory study of lomefloxacin (NY-198 or SC 47111) antimicrobial activity in Argentina.
Bianchini HN; Sarachian B; Fernandez A; Paolasso R; Kaufman C; Notario R; Porven G; Ingaramo RA; Perez S; Ferrero SM
Diagn Microbiol Infect Dis; 1989; 12(3 Suppl):45S-50S. PubMed ID: 2676328
[TBL] [Abstract][Full Text] [Related]
18. Hydrophobicity and serum sensitivity of Klebsiella pneumoniae treated with sub-MICs of quinolones.
Hostacká A
Microbios; 1997; 91(368-369):137-43. PubMed ID: 9523422
[TBL] [Abstract][Full Text] [Related]
19. In vitro activity of lomefloxacin, a difluorinated quinolone, compared with other antimicrobials.
Qadri SM; Lee GC; Ellis ME
Chemotherapy; 1991; 37(3):166-74. PubMed ID: 1889304
[TBL] [Abstract][Full Text] [Related]
20. Studies on the emergence of resistance to lomefloxacin in vitro.
Kanematsu M; Greenwood D
Eur J Clin Microbiol Infect Dis; 1989 Aug; 8(8):741-5. PubMed ID: 2506046
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
